Ubichem, a leading provider of chemistry services to the drug development sector, through its Hungarian

The U.S. Food and Drug Administration today warned consumers not to purchase or use a product called

The U.S. Food and Drug Administration today announced a new initiative to address safety problems associated with external infusion pumps, which are

“Spider and reticular veins are a common, often embarrassing condition that can be treated safely and

April 22, 2010 – Genentech, Inc., a wholly owned member of the Roche Group, announced today that the company submitted a supplemental Biologics License Application

Genentech, Inc., a wholly owned member of the Roche Group, announced today that the U.S. Food and Drug

ADIENNE Pharma & Biotech and RIEMSER Arzneimittel AG announce today that the European Medicines Agency (EMA) has granted

Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec announced today the U.S. Food and Drug Administration (FDA)

A minimally invasive surgical approach developed by head and neck surgeons at the University of Pennsylvania School of Medicine has been cleared by the U.S. Food and Drug Administration (FDA).

April 1, 2009 – QIAGEN Gaithersburg Inc. (formerly Digene Corporation), a wholly-owned subsidiary of QIAGEN N.V. (NASDAQ: QGEN) today announced the U.S. Court of Appeals